Safety and tolerability of a new formulation (90 mg/kg/day divided every 12h) of amoxicillin/clavulanate (Augmentin^( !R)) in the empiric treatment of pediatric acute otitis media caused by drug-resistant Streptococcus pneumoniae
収録刊行物
-
- Pediatr. Infect. Dis. J.
-
Pediatr. Infect. Dis. J. 17 963-968, 1998